|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Receptor in a Newborn Rat Model of Endothelin-Mediated Pulmonary Vascular Remodeling
1 Clinical Integrative Biology, Sunnybrook & Women's Research Institute, Toronto, Ontario, Canada
* To whom correspondence should be addressed. E-mail: robert.jankov{at}sw.ca.
Newborn rats exposed to 60% O2 for 14 days develop endothelin (ET)-1-dependent pulmonary
hypertension with vascular remodeling, characterized by increased smooth muscle cell (SMC)
proliferation and medial thickening of pulmonary resistance arteries. Using immunohistochemistry
and Western blot analyses, we examined the effect of exposure to 60% O2 on expression in the lung of
receptors for the platelet-derived growth factors (PDGFs), which are implicated in the pathogenesis of
arterial smooth muscle hyperplasia. We observed a marked O2-induced up-regulation of PDGF-
and
-
receptors (PDGF-
R and -
R) on arterial smooth muscle. This led us to examine pulmonary
vascular PDGF receptor expression in 60% O2-exposed rats given SB217242, a combined ET receptor
antagonist, which we found prevented the O2-induced up-regulation of PDGF-
R, but not the -
R, on arterial smooth muscle. PDGF-BB, a major PDGF-
R ligand, was found to be a potent in vitro
inducer of hyperplasia and DNA synthesis in cultured pulmonary artery SMCs from infant rats. A
critical role for PDGF-
R ligands in arterial SMC proliferation was confirmed in vivo using a
truncated soluble PDGF-
R intervention, which attenuated SMC proliferation induced by exposure to
60% O2. Collectively, these data are consistent with a major role for PDGF-
R-mediated SMC
proliferation, acting downstream of increased ET-1 in a newborn rat model of 60% O2-induced
pulmonary hypertension.
This article has been cited by other articles:
![]() |
P. J. McNamara, P. Murthy, C. Kantores, L. Teixeira, D. Engelberts, T. van Vliet, B. P. Kavanagh, and R. P. Jankov Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L205 - L213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Jankov, C. Kantores, J. Pan, and J. Belik Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L233 - L245. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kantores, P. J. McNamara, L. Teixeira, D. Engelberts, P. Murthy, B. P. Kavanagh, and R. P. Jankov Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L912 - L922. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C.H. Hsieh, C. MacGillivray, J. Gannon;, F. U. Cruz, and R. T. Lee Local Controlled Intramyocardial Delivery of Platelet-Derived Growth Factor Improves Postinfarction Ventricular Function Without Pulmonary Toxicity Circulation, August 15, 2006; 114(7): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |